These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4084667)

  • 41. Alterations in prednisolone disposition as a result of time of administration, gender and dose.
    Meffin PJ; Brooks PM; Sallustio BC
    Br J Clin Pharmacol; 1984 Apr; 17(4):395-404. PubMed ID: 6721985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma and salivary pharmacokinetics of caffeine in man.
    Newton R; Broughton LJ; Lind MJ; Morrison PJ; Rogers HJ; Bradbrook ID
    Eur J Clin Pharmacol; 1981; 21(1):45-52. PubMed ID: 7333346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of prednisolone with azathioprine and prednisolone with intramuscular gold in rheumatoid arthritis.
    Häntzschel H; Otto W; Arnold S; Seidel W; Krüger W; Winiecki P; Bird HA; Dixon JS; Astbury G; Wright V
    Clin Rheumatol; 1988 Jun; 7(2):181-7. PubMed ID: 3138060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urinary excretion of prednisolone following intravenous administration in humans.
    al-Habet SM; Rogers HJ
    J Clin Pharmacol; 1989 Oct; 29(10):922-7. PubMed ID: 2592584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of dexamethasone and its phosphate ester.
    Rohdewald P; Möllmann H; Barth J; Rehder J; Derendorf H
    Biopharm Drug Dispos; 1987; 8(3):205-12. PubMed ID: 3593899
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced prednisolone elimination: a possible cause for failure of glucocorticoid therapy in Graves' ophthalmopathy.
    Legler UF
    Horm Metab Res; 1987 Apr; 19(4):168-70. PubMed ID: 3583222
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prednisolone pharmacokinetics in patients with rheumatoid arthritis, polymyalgia rheumatica and asthma.
    Taggart AJ; Astbury C; Dixon JS; Bird HA
    Clin Rheumatol; 1986 Sep; 5(3):327-31. PubMed ID: 3780140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Allergic reactions after systemic administration of glucocorticosteroid therapy.
    Alexiou C; Kau RJ; Luppa P; Arnold W
    Arch Otolaryngol Head Neck Surg; 1998 Nov; 124(11):1260-4. PubMed ID: 9821930
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pharmacokinetics of prednisolone administered to cows in the form of a prednisolone acetate solution in dimethyl sulfoxide in association with antibiotics].
    Oukessou M; Alvinerie M; Toutain PL
    Ann Rech Vet; 1987; 18(3):217-25. PubMed ID: 3426108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Altered prednisolone pharmacokinetics in patients with cystic fibrosis.
    Dove AM; Szefler SJ; Hill MR; Jusko WJ; Larsen GL; Accurso FJ
    J Pediatr; 1992 May; 120(5):789-94. PubMed ID: 1578318
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hydrolysis of prednisolone succinate by esterase in rabbit ocular tissue.
    Tsuji A; Tamai I; Sasaki K
    Ophthalmic Res; 1987; 19(6):322-9. PubMed ID: 3441354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Separation of serum prednisolone and prednisolone-21-hemisuccinate by extraction and their concurrent determination by radioimmunoassay.
    Yanagibashi K; Mizuchi A; Yotsumoto H; Miyachi Y
    Clin Chem; 1980 Aug; 26(9):1301-3. PubMed ID: 7398044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.
    Danhof M; van Zuilen A; Boeijinga JK; Breimer DD
    Eur J Clin Pharmacol; 1982; 21(5):433-41. PubMed ID: 7075648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of inflammatory bowel disease on absorption and disposition of prednisolone.
    Milsap RL; George DE; Szefler SJ; Murray KA; Lebenthal E; Jusko WJ
    Dig Dis Sci; 1983 Feb; 28(2):161-8. PubMed ID: 6825536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function.
    Frey BM; Walker C; Frey FJ; de Weck AL
    J Immunol; 1984 Nov; 133(5):2479-87. PubMed ID: 6237151
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man.
    Wald JA; Law RM; Ludwig EA; Sloan RR; Middleton E; Jusko WJ
    J Pharmacokinet Biopharm; 1992 Dec; 20(6):567-89. PubMed ID: 1302763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect on nephrotic syndrome on absorption and disposition of prednisolone in children.
    Rocci ML; Assael BM; Appiani AC; Edefonti A; Jusko WJ
    Int J Pediatr Nephrol; 1982 Sep; 3(3):159-66. PubMed ID: 7141787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Altered plasma protein-binding of prednisolone in patients with the nephrotic syndrome.
    Frey FJ; Frey BM
    Am J Kidney Dis; 1984 Mar; 3(5):339-48. PubMed ID: 6702820
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics and delta1-cortienic acid excretion after intravenous administration of prednisolone and loteprednol etabonate in rats.
    Wu WM; Tang Y; Buchwald P; Bodor N
    Pharmazie; 2010 Jun; 65(6):412-6. PubMed ID: 20614688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of betamethasone in healthy adults after intravenous administration.
    Petersen MC; Nation RL; McBride WG; Ashley JJ; Moore RG
    Eur J Clin Pharmacol; 1983; 25(5):643-50. PubMed ID: 6662164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.